These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7047681)

  • 1. Comparison of safety and immunogenicity of ADW and AYW hepatitis B vaccines.
    Papaevangelou GJ; Vissoulis CG; Roumeliotou-Karayannis AJ; Kolaitis N; Krugman S
    J Med Virol; 1982; 9(3):231-6. PubMed ID: 7047681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.
    Dienstag JL; Werner BG; Polk BF; Snydman DR; Craven DE; Platt R; Crumpacker CS; Ouellet-Hellstrom R; Grady GF
    Ann Intern Med; 1984 Jul; 101(1):34-40. PubMed ID: 6233921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune response of healthy Nigerian adults to small doses of hepatitis B vaccine: comparison of 10- and 20-micrograms doses.
    Ayoola EA
    J Med Virol; 1984; 13(3):223-5. PubMed ID: 6726191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a five-microgram dose of hepatitis B vaccine.
    Papaevangelou G; Roumeliotou-Karayannis A; Vissoulis C; Richardson SC; Krugman S
    J Med Virol; 1985 Jan; 15(1):65-9. PubMed ID: 3155792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of two recombinant hepatitis B vaccines in older individuals.
    Treadwell TL; Keeffe EB; Lake J; Read A; Friedman LS; Goldman IS; Howell CD; DeMedina M; Schiff ER; Jensen DM
    Am J Med; 1993 Dec; 95(6):584-8. PubMed ID: 8259774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine: safety study in anti-HBs seronegative human volunteers.
    Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
    Dev Biol Stand; 1983; 54():229-35. PubMed ID: 6228463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
    Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
    Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a reduced dose of hepatitis B vaccine administered intradermally.
    Zoulek G; Lorbeer B; Jilg W; Deinhardt F
    J Med Virol; 1984; 14(1):27-32. PubMed ID: 6747610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity in chimpanzees of experimental hepatitis B vaccines prepared from intact hepatitis B virus, purified polypeptides, or polypeptide micelles.
    Tabor E; Howard CR; Skelly J; Snoy P; Goudeau A; Zuckerman AJ; Gerety RJ
    J Med Virol; 1982; 10(1):65-74. PubMed ID: 7130967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine comprising a synthetic antigen in healthy adults.
    Aguilar-Betancourt A; González-Delgado CA; Cinza-Estévez Z; Martínez-Cabrera J; Véliz-Ríos G; Alemán-Zaldívar R; Alonso-Martínez MI; Lago-Baños M; Puble-Alvarez N; Delahanty-Fernandez A; Juvier-Madrazo AI; Ortega-León D; Olivera-Ruano L; Correa-Fernández A; Abreu-Reyes D; Soto-Mestre E; Pérez-Pérez MV; Figueroa-Baile N; Pérez LH; Rodríguez-Silva A; Martínez-Díaz E; Guillén-Nieto GE; Muzio-González VL
    Hum Vaccin; 2008; 4(1):54-9. PubMed ID: 18441530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B surface antigen (HBsAg) subtype-specific antibodies in persons vaccinated against hepatitis B.
    Jilg W; Delhoune C; Deinhardt F; Roumeliotou-Karayannis AJ; Papaevangelou GJ; Mushahwar IK; Overby LR
    J Med Virol; 1984; 13(2):171-8. PubMed ID: 6198457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants.
    Maldonado Y; Hestvik L; Wilson M; Townsend T; O'Hare J; Wee S; Yolken R
    J Pediatr; 1986 Dec; 109(6):931-5. PubMed ID: 3537248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune response of healthy adults to a reduced dose of hepatitis B vaccine.
    Szmuness W; Stevens CE; Harley EJ; Zang EA; Taylor PE; Alter HJ
    J Med Virol; 1981; 8(2):123-9. PubMed ID: 7299378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus vaccination for older adults.
    Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
    J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
    Shinefield HR; Black S; Ray P; Chang I; Lewis N; Fireman B; Hackell J; Paradiso PR; Siber G; Kohberger R; Madore DV; Malinowski FJ; Kimura A; Le C; Landaw I; Aguilar J; Hansen J
    Pediatr Infect Dis J; 1999 Sep; 18(9):757-63. PubMed ID: 10493334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a recombinant hepatitis B vaccine.
    Dandolos E; Roumeliotou-Karayannis A; Richardson SC; Papaevangelou G
    J Med Virol; 1985 Sep; 17(1):57-62. PubMed ID: 4045435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.
    Kanesa-thasan N; Sun W; Kim-Ahn G; Van Albert S; Putnak JR; King A; Raengsakulsrach B; Christ-Schmidt H; Gilson K; Zahradnik JM; Vaughn DW; Innis BL; Saluzzo JF; Hoke CH
    Vaccine; 2001 Apr; 19(23-24):3179-88. PubMed ID: 11312014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of immune response to hepatitis B (HB) vaccine (Pasteur) in adults.
    Giunchi G; Panichi G; Pescini A; Pezzella M; Galli C; Chircu LV; Sorice F
    Dev Biol Stand; 1983; 54():153-9. PubMed ID: 6228454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.